Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 December 2020 | Story André Damons | Photo Supplied
Dr Michael Pienaar is a lecturer in the University of the Free State’s (UFS) department of Paediatrics and Child Health.

A lecturer from the University of the Free State’s (UFS) department of Paediatrics and Child Health is investigating the use of artificial neural networks to develop models for the prediction of patient outcomes in children with severe illness.

Dr Michael Pienaar, senior lecturer and specialist, is conducting this research as part of his doctoral research and the study deals primarily with the development of models that are designed and calibrated for use in South Africa. These artificial neural networks are computer programs designed to mimic some of the learning characteristics of biological neurons.

The potential applications of models

According to Dr Pienaar these models have traditionally been developed in high-income nations using conventional statistical methods.

“The potential applications of such models in the clinical setting include triage, medical research, guidance of resource allocation and quality control. Having initially begun this research investigating the prediction of mortality outcomes in the paediatric intensive care unit (PICU) I have broadened my scope to patients outside of PICU, seeking to identify children early during their illnesses who are at risk of serious illness requiring PICU,” says Dr Pienaar.

The research up until now has been directed towards the identification of characteristics that are both unique to children with serious illness in South Africa, but also accessible to clinicians in settings where expertise and technical resources are limited.

Research still in the early changes

The research is still in its early stages but next year a series of expert review panels will be held to investigate the selection of variables for the model, after which the collection of clinical data will begin. Once the data has been collected and prepared, a number of candidate models will be developed and evaluated. This should be concluded by the end of 2022.

Says Dr Pienaar: “The need to engage with the rapid proliferation of technology, particularly in the realms of machine learning, mobile technology, automation and the Internet of Things is as great in medical research now as it is in any academic discipline.

“It is critical that research, particularly in South Africa, engage with this in order to take advantage of the opportunities offered and avoid the dangers that go paired with them. Together with the technology as such, it has been essential to pursue this project as an interdisciplinary undertaking involving clinicians, biostatisticians and computer engineers.”

Hope for the research  

Dr Pienaar says he was very fortunate and grateful to be the recipient of a generous interdisciplinary grant from the UFS which has allowed him to procure software and equipment that is critical to this project.

“The hope for this research is that the best performing of these models can be integrated with a mobile application that assists practitioners in a wide range of settings in the identification, treatment and early referral of children at high risk of severe illness. I would like to expand this research project to include other countries in Africa and South America and to use it as a bridge to collaboration with other clinical researchers in the Global South,” says Dr Pienaar.

As an early career researcher, Dr Pienaar hopes that this research can serve as a platform to build a body of research that uses the rapid technological advances of these times together with a wide range of collaborations with other disciplines in the pursuit of better child health.

He concludes by saying that he has had excellent support thus far from his supervisors, Prof Stephen Brown (Faculty of Health Sciences, UFS), Dr Nicolaas Luwes (Faculty of Computer Science and Engineering, Central University of Technology) and Dr Elizabeth George (Medical Research Council Clinical Trials Unit, University College London). I have also been supported by the Robert Frater Institute in the Faculty of Health Sciences.

News Archive

UFS launches expansions to Biotechnology Building
2015-11-04

     

Biotechnology Building
Photo: Leonie Bolleurs

To support the strategic focus of the University of the Free State (UFS) on teaching and learning in the field of Biotechnology, the Department of Microbial, Biochemical, and Food Biotechnology introduced upgrades and additions to the value of R23 million to the existing Biotechnology Building on its Bloemfontein Campus. The funding was provided by the Department of Higher Education and Training.

The new section, together with renovations to the existing part of the Biotechnology Building, was opened on Thursday 29 October 2015.

The Department, consisting of three disciplines - Microbiology, Biochemistry, and Food Biotechnology - is extremely diverse. Two of the three disciplines – Microbiology and Biochemistry – are housed in the Biotechnology Building.

Additions and renovations to the Biotechnology Building include:
-    Four new research laboratories
-    Nine revamped research laboratories

      

At the launch of the Biotechnology Building were,
from the left: Nico Janse van Rensburg,
Senior Director: University Estates;
Maureen Khati, University Estates,
Prof Nicky Morgan, Vice Rector: Operations
and Ria Deysel, Director: Facilities Management.
Photo: Leonie Bolleurs

The work to the building will have dramatic effects on the quality, as well as the quantity, of postgraduate students. Given the national priority to deliver students, this is very important, particularly at the doctorate level.

Prof Koos Albertyn from the Department said these were the first renovations and expansions done to the building since 1 January 1990. “We welcome the extra space. Forty-six more postgraduate students can now be accommodated in the department,” he said.

Construction took place on the south-western corner of the existing building. Further developments to the building include:
-    Six new offices
-    A lecture hall for 70 students
-    Laboratories that can accommodate 56 postgraduate students

Prof Martie Smit, Academic Head of the Department, said: “This new and refurbished facility enables us to give our best. As academics, we are committed to doing our part in delivering high-quality education at both undergraduate and postgraduate levels to students envisaging a future in biotechnology.”

The James Charles du Preez Seminar Room was also opened at the event. The seminar room is dedicated to Prof Du Preez – who was Head of the Department from October 2002 until the end of 2014. He played a major role in raising funds for upgrading the Biotechnology Building, including the addition of a new wing.



We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept